HomeCompareVMTHF vs QYLD

VMTHF vs QYLD: Dividend Comparison 2026

VMTHF yields 474.05% · QYLD yields 12.24%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VMTHF wins by $40760.08M in total portfolio value
10 years
VMTHF
VMTHF
● Live price
474.05%
Share price
$0.42
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40760.11M
Annual income
$28,806,329,273.60
Full VMTHF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
12.24%
Share price
$16.70
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$6,038.84
Full QYLD calculator →

Portfolio growth — VMTHF vs QYLD

📍 VMTHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVMTHFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VMTHF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VMTHF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VMTHF
Annual income on $10K today (after 15% tax)
$40,293.91/yr
After 10yr DRIP, annual income (after tax)
$24,485,379,882.56/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,040.82/yr
After 10yr DRIP, annual income (after tax)
$5,133.01/yr
At 15% tax rate, VMTHF beats the other by $24,485,374,749.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VMTHF + QYLD for your $10,000?

VMTHF: 50%QYLD: 50%
100% QYLD50/50100% VMTHF
Portfolio after 10yr
$20380.07M
Annual income
$14,403,167,656.22/yr
Blended yield
70.67%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VMTHF buys
0
QYLD buys
0
No recent congressional trades found for VMTHF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVMTHFQYLD
Forward yield474.05%12.24%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$40760.11M$26.5K
Annual income after 10y$28,806,329,273.60$6,038.84
Total dividends collected$39707.63M$28.5K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: VMTHF vs QYLD ($10,000, DRIP)

YearVMTHF PortfolioVMTHF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$58,105$47,404.60$10,384$1,224.49+$47.7KVMTHF
2$319,595$257,422.91$10,900$1,388.18+$308.7KVMTHF
3$1,665,249$1,323,282.78$11,576$1,590.76+$1.65MVMTHF
4$8,225,711$6,443,893.93$12,447$1,844.20+$8.21MVMTHF
5$38,549,580$29,748,069.43$13,567$2,164.97+$38.54MVMTHF
6$171,541,094$130,293,043.94$15,003$2,576.05+$171.53MVMTHF
7$725,407,583$541,858,612.30$16,853$3,110.04+$725.39MVMTHF
8$2,917,676,445$2,141,490,330.46$19,251$3,813.85+$2917.66MVMTHF
9$11,171,756,198$8,049,842,402.84$22,390$4,756.08+$11171.73MVMTHF
10$40,760,108,406$28,806,329,273.60$26,548$6,038.84+$40760.08MVMTHF

VMTHF vs QYLD: Complete Analysis 2026

VMTHFStock

Venus Medtech (Hangzhou) Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; and transcatheter mitral and tricuspid valve replacement products; Liwen RF ablation system for the treatment of hypertrophic cardiomyopathy; and renal denervation for the treatment of hypertension. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.

Full VMTHF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this VMTHF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VMTHF vs SCHDVMTHF vs JEPIVMTHF vs OVMTHF vs KOVMTHF vs MAINVMTHF vs XYLDVMTHF vs JEPQVMTHF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.